WILLIAM JOHNSON: Open Payments
NPI 1669586996 · BRANDON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,077 in 58 payments from 16 companies in 2025. Trend: 2023 $1,684 · 2024 $1,406 · 2025 $1,077
Food & beverage: $1,077
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $356 |
| Axsome Therapeutics, Inc. | 9 | $159 |
| JAZZ PHARMACEUTICALS INC. | 4 | $128 |
| Otsuka America Pharmaceutical, Inc. | 4 | $80 |
| Janssen Pharmaceuticals, Inc | 2 | $49 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $47 |
| Neurocrine BioSciences, Inc. | 2 | $42 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $37 |
| Teva Pharmaceuticals USA, Inc. | 2 | $35 |
| Alkermes, Inc. | 1 | $29 |
Products named: VRAYLAR, Auvelity, XYWAV, REXULTI, TRINTELLIX, INGREZZA, AUSTEDO XR, ARISTADA.
Industry payments across MS — which companies pay providers there.
